Headlines

Second Sight Completes Merger and Changes Its Name

The developer of implantable visual prosthetics combined with Nano Precision Medical.

Published

2 years ago

September 1, 2022

Second Sight Medical Products Inc. has completed its merger with Nano Precision Medical Inc.

Second Sight a developer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals. NPM is a biopharmaceutical business that develops miniaturized subdermal drug implants using its NanoPortal technology for delivery of medicines to treat chronic diseases.

In connection with the merger, Second Sight changed its name to Vivani Medical Inc. The company’s common stock will trade on the Nasdaq Capital Market under the symbol “VANI.”

Upon completion of the merger, Vivani has approximately $55 million in cash to advance the development of its portfolio. It’s seeking to move lead asset NPM-119 (exenatide implant) into clinical-stage development for the treatment of patients with Type 2 diabetes and to advance its clinical-stage Orion visual prosthetic device to treat individuals with blindness.

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width³ according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion⁴ and seamless transitions from near to far.

For more information, visit here.